{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:01:33Z","timestamp":1785542493023,"version":"3.56.0"},"reference-count":163,"publisher":"Japanese Circulation Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,4,24]]},"DOI":"10.1253\/circj.cj-25-0220","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T18:07:34Z","timestamp":1749751654000},"page":"466-479","source":"Crossref","is-referenced-by-count":4,"title":["Iron Deficiency in Cardiovascular Disease\u3000\u2015 Diagnosis, Clinical Implications, and Future Directions \u2015"],"prefix":"10.1253","volume":"90","author":[{"given":"Fraser John","family":"Graham","sequence":"first","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow"},{"name":"Queen Elizabeth University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Masini","sequence":"additional","affiliation":[{"name":"University of Pisa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Lakhal-Littleton","sequence":"additional","affiliation":[{"name":"University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L","family":"Clark","sequence":"additional","affiliation":[{"name":"Hull University Hospitals NHS Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John George Franklin","family":"Cleland","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Pellicori","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maeder MT, Khammy O, Dos Remedios C, Kaye DM. Myocardial and systemic iron depletion in heart failure: Implications for anemia accompanying heart failure. <i>J Am Coll Cardiol<\/i> 2011; 58: 474\u2013480.","DOI":"10.1016\/j.jacc.2011.01.059"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Melenovsky V, Petrak J, Mracek T, Benes J, Borlaug BA, Nuskova H, et al. Myocardial iron content and mitochondrial function in human heart failure: A direct tissue analysis. <i>Eur J Heart Fail<\/i> 2017; 19: 522\u2013530.","DOI":"10.1002\/ejhf.640"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kasner M, Aleksandrov AS, Westermann D, Lassner D, Gross M, Von Haehling S, et al. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction. <i>Int J Cardiol<\/i> 2013; 168: 4652\u20134657.","DOI":"10.1016\/j.ijcard.2013.07.185"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Leszek P, Sochanowicz B, Szperl M, Kolsut P, Brz\u00f3ska K, Piotrowski W, et al. Myocardial iron homeostasis in advanced chronic heart failure patients. <i>Int J Cardiol<\/i> 2012; 159: 47\u201352.","DOI":"10.1016\/j.ijcard.2011.08.006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. <i>Lancet<\/i> 2007; 370: 511\u2013520.","DOI":"10.1016\/S0140-6736(07)61235-5"},{"key":"6","unstructured":"6. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. WHO, 2011. http:\/\/scholar.google.com\/scholar?hl=en&amp;btnG=Search&amp;q=intitle: Haemoglobin+concentrations+for+the+diagnosis+of+anaemia+and+assessment+of+severity#1 (accessed March 31, 2020)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, et al. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. <i>J Card Fail<\/i> 2011; 17: 899\u2013906.","DOI":"10.1016\/j.cardfail.2011.08.003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mero\u00f1o O, Cladellas M, Ribas-Barquet N, Poveda P, Recasens L, Baz\u00e1n V, et al. Iron deficiency is a determinant of functional capacity and health-related quality of life 30 days after an acute coronary syndrome. <i>Rev Esp Cardiol (English Edn)<\/i> 2017; 70: 363\u2013370.","DOI":"10.1016\/j.rec.2016.10.004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Com\u00edn-Colet J, Enjuanes C, Gonz\u00e1lez G, Torrens A, Cladellas M, Mero\u00f1o O, et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. <i>Eur J Heart Fail<\/i> 2013; 15: 1164\u20131172.","DOI":"10.1093\/eurjhf\/hft083"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Beale AL, Warren JL, Roberts N, Meyer P, Townsend NP, Kaye D. Iron deficiency in heart failure with preserved ejection fraction: A systematic review and meta-analysis. <i>Open Heart<\/i> 2019; 6: e001012.","DOI":"10.1136\/openhrt-2019-001012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cl\u00e9nin GE, Cordes M, Huber A, Schumacher Y, Noack P, Scales J, et al. Iron deficiency in sports: Definition, influence on performance and therapy. <i>Swiss Med Wkly<\/i> 2015; 145: w14196.","DOI":"10.4414\/smw.2015.14196"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Haas JD, Brownlie T. Iron deficiency and reduced work capacity: A critical review of the research to determine a causal relationship. <i>J Nutr<\/i> 2001; 131: 676S\u2013690S.","DOI":"10.1093\/jn\/131.2.676S"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Blanton CA, Green MW, Kretsch MJ. Body iron is associated with cognitive executive planning function in college women. <i>Br J Nutr<\/i> 2013; 109: 906\u2013913.","DOI":"10.1017\/S0007114512002620"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, et al. Iron deficiency: An ominous sign in patients with systolic chronic heart failure. <i>Eur Heart J<\/i> 2010; 31: 1872\u20131880.","DOI":"10.1093\/eurheartj\/ehq158"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Ole\u015bkowska-Florek W, et al. Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. <i>Eur Heart J<\/i> 2014; 35: 2468\u20132476.","DOI":"10.1093\/eurheartj\/ehu235"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cleland JGF, Zhang J, Pellicori P, Dicken B, Dierckx R, Shoaib A, et al. Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. <i>JAMA Cardiol<\/i> 2016; 1: 539\u2013547.","DOI":"10.1001\/jamacardio.2016.1161"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Beverborg NG, Klip IjT, Meijers WC, Voors AA, Vegter EL, Van Der Wal HH, et al. Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients. <i>Circ Heart Fail<\/i> 2018; 11: e004519.","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Corti MC, Guralnik JM, Salive ME, Ferrucci L, Pahor M, Wallace RB, et al. Serum iron level, coronary artery disease, and all-cause mortality in older men and women. <i>Am J Cardiol<\/i> 1997; 79: 120\u2013127.","DOI":"10.1016\/S0002-9149(96)00697-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Dziegala M, Josiak K, Kasztura M, Kobak K, von Haehling S, Banasiak W, et al. Iron deficiency as energetic insult to skeletal muscle in chronic diseases. <i>J Cachexia Sarcopenia Muscle<\/i> 2018; 9: 802\u2013815.","DOI":"10.1002\/jcsm.12314"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lam JR, Schneider JL, Quesenberry CP, Corley DA. Proton pump inhibitor and histamine-2 receptor antagonist use and iron deficiency. <i>Gastroenterology<\/i> 2017; 152: 821\u2013829.e1.","DOI":"10.1053\/j.gastro.2016.11.023"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Graham FJ, Friday JM, Pellicori P, Greenlaw N, Cleland JGF. Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease. <i>Heart<\/i> 2023; 109: 1294\u20131301.","DOI":"10.1136\/heartjnl-2022-322145"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mistry R, Hosoya H, Kohut A, Ford P. Iron deficiency in heart failure, an underdiagnosed and undertreated condition during hospitalization. <i>Ann Hematol<\/i> 2019; 98: 2293\u20132297.","DOI":"10.1007\/s00277-019-03777-w"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. <i>Lancet<\/i> 2016; 387: 907\u2013916.","DOI":"10.1016\/S0140-6736(15)60865-0"},{"key":"24","unstructured":"24. Wallace DF. The regulation of iron absorption and homeostasis. <i>Clin Biochem Rev<\/i> 2016; 37: 51\u201362."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Andrews NC. Forging a field: The golden age of iron biology. <i>Blood<\/i> 2008; 112: 219\u2013230.","DOI":"10.1182\/blood-2007-12-077388"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mu\u00f1oz M, Garc\u00eda-Erce JA, Remacha \u00c1F. Disorders of iron metabolism. Part 1: Molecular basis of iron homoeostasis. <i>J Clin Pathol<\/i> 2011; 64: 281\u2013286.","DOI":"10.1136\/jcp.2010.079046"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Salovaara S, Sandberg AS, Andlid T. Combined impact of pH and organic acids on iron uptake by Caco-2 cells. <i>J Agric Food Chem<\/i> 2003; 51: 7820\u20137824.","DOI":"10.1021\/jf030177n"},{"key":"28","unstructured":"28. Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. <i>J Res Med Sci<\/i> 2014; 19: 164\u2013174."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Andrews NC. Disorders of iron metabolism. <i>N Engl J Med<\/i> 1999; 341: 1986\u20131995.","DOI":"10.1056\/NEJM199912233412607"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Nemeth E, Tuttle MS, Powelson J, Vaughn MD, Donovan A, Ward DMV, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. <i>Science<\/i> 2004; 306: 2090\u20132093.","DOI":"10.1126\/science.1104742"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Nemeth E, Ganz T. The role of hepcidin in iron metabolism. <i>Acta Haematol<\/i> 2009; 12: 278\u2013286.","DOI":"10.1159\/000243791"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Bozzini C, Girelli D, Tinazzi E, Olivieri O, Stranieri C, Bassi A, et al. Biochemical and genetic markers of iron status and the risk of coronary artery disease: An angiography-based study. <i>Clin Chem<\/i> 2002; 48: 622\u2013628.","DOI":"10.1093\/clinchem\/48.4.622"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Jankowska EA, Wojtas K, Kasztura M, Mazur G, Butrym A, Kalicinska E, et al. Bone marrow iron depletion is common in patients with coronary artery disease. <i>Int J Cardiol<\/i> 2015; 182: 517\u2013522.","DOI":"10.1016\/j.ijcard.2014.10.006"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Zeller T, Waldeyer C, Ojeda F, Schnabel RB, Sch\u00e4fer S, Altay A, et al. Adverse outcome prediction of iron deficiency in patients with acute coronary syndrome. <i>Biomolecules<\/i> 2018; 8: 60.","DOI":"10.3390\/biom8030060"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, et al. Iron deficiency in chronic heart failure: An international pooled analysis. <i>Am Heart J<\/i> 2013; 165: 575\u2013582.e3.","DOI":"10.1016\/j.ahj.2013.01.017"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Okonko DO, Mandal AKJ, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis in chronic heart failure: Prevalence, predictors, and relation to anemia, exercise capacity, and survival. <i>J Am Coll Cardiol<\/i> 2011; 58: 1241\u20131251.","DOI":"10.1016\/j.jacc.2011.04.040"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Tkaczyszyn M, Com\u00edn-Colet J, Voors AA, van Veldhuisen DJ, Enjuanes C, Moliner-Borja P, et al. Iron deficiency and red cell indices in patients with heart failure. <i>Eur J Heart Fail<\/i> 2018; 20: 114\u2013122.","DOI":"10.1002\/ejhf.820"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Bekfani T, Pellicori P, Morris D, Ebner N, Valentova M, Sandek A, et al. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life. <i>Clin Res Cardiol<\/i> 2019; 108: 203\u2013211.","DOI":"10.1007\/s00392-018-1344-x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. N\u00fa\u00f1ez J, Com\u00edn-Colet J, Mi\u00f1ana G, N\u00fa\u00f1ez E, Santas E, Mollar A, et al. Iron deficiency and risk of early readmission following a hospitalization for acute heart failure. <i>Eur J Heart Fail<\/i> 2016; 18: 798\u2013802.","DOI":"10.1002\/ejhf.513"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Cohen-Solal A, Damy T, Terbah M, Kerebel S, Baguet JP, Hanon O, et al. High prevalence of iron deficiency in patients with acute decompensated heart failure. <i>Eur J Heart Fail<\/i> 2014; 16: 984\u2013991.","DOI":"10.1002\/ejhf.139"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Miles LF, Kunz SA, Na LH, Braat S, Burbury K, Story DA. Postoperative outcomes following cardiac surgery in non-anaemic iron-replete and iron-deficient patients: An exploratory study. <i>Anaesthesia<\/i> 2018; 73: 450\u2013458.","DOI":"10.1111\/anae.14115"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Piednoir P, Allou N, Driss F, Longrois D, Philip I, Beaumont C, et al. Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: A prospective observational study. <i>Eur J Anaesthesiol<\/i> 2011; 28: 793\u2013801.","DOI":"10.1097\/EJA.0b013e32834ad97b"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Masini G, Graham FJ, Pellicori P, Cleland JGF, Cuthbert J, Kazmi S, et al. Criteria for iron deficiency in patients with heart failure. <i>J Am Coll Cardiol<\/i> 2022; 79: 341\u2013351.","DOI":"10.1016\/j.jacc.2021.11.039"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I. Guideline for the laboratory diagnosis of functional iron deficiency. <i>Br J Haematol<\/i> 2013; 161: 639\u2013648.","DOI":"10.1111\/bjh.12311"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Gale E, Torrance J, Bothwell T. The quantitative estimation of total iron stores in human bone marrow. <i>J Clin Invest<\/i> 1963; 42: 1076\u20131082.","DOI":"10.1172\/JCI104793"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Ponikowski P, Mentz RJ, Hernandez AF, Butler J, Khan MS, van Veldhuisen DJ, et al. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: An individual patient data meta-analysis. <i>Eur Heart J<\/i> 2023; 44: 5077\u20135091.","DOI":"10.1093\/eurheartj\/ehad586"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Graham FJ, Pellicori P, Kalra PR, Ford I, Bruzzese D, Cleland JGF. Intravenous iron in patients with heart failure and iron deficiency: An updated meta-analysis. <i>Eur J Heart Fail<\/i> 2023; 25: 528\u2013537.","DOI":"10.1002\/ejhf.2810"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Packer M, Anker SD, Butler J, Cleland JGF, Kalra PR, Mentz RJ, et al. Redefining iron deficiency in patients with chronic heart failure. <i>Circulation<\/i> 2024; 150: 151\u2013161.","DOI":"10.1161\/CIRCULATIONAHA.124.068883"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Packer M, Anker SD, Butler J, Cleland JGF, Kalra PR, Mentz RJ, et al. Critical re-evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure. <i>Eur J Heart Fail<\/i> 2024; 26: 1298\u20131312.","DOI":"10.1002\/ejhf.3237"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Patel KV. Variability and heritability of hemoglobin concentration: An opportunity to improve understanding of anemia in older adults. <i>Haematologica<\/i> 2008; 93: 1281\u20131283.","DOI":"10.3324\/haematol.13692"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Beutler E, Waalen J. The definition of anemia: What is the lower limit of normal of the blood hemoglobin concentration? <i>Blood<\/i> 2006; 107: 1747\u20131750.","DOI":"10.1182\/blood-2005-07-3046"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Olthof AW, Sijens PE, Kreeftenberg HG, Kappert P, Irwan R, van der Jagt EJ, et al. Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: Impact of hematologic disease and inflammation. <i>Magn Reson Imaging<\/i> 2007; 25: 228\u2013231.","DOI":"10.1016\/j.mri.2006.09.019"},{"key":"53","unstructured":"53. World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. World Health Organization, 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240000124 (accessed November 29, 2021)."},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Goddard AF, James MW, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. <i>Gut<\/i> 2011; 60: 1309\u20131316.","DOI":"10.1136\/gut.2010.228874"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. <i>Blood<\/i> 2010; 116: 4754\u20134761.","DOI":"10.1182\/blood-2010-05-286260"},{"key":"56","unstructured":"56. World Health Organization. Serum ferritin concentrations for assessment of iron status and iron deficiency in populations. WHO, 2011 (accessed September 15, 2020)."},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: An overview. <i>J Gen Intern Med<\/i> 1992; 7: 145\u2013153.","DOI":"10.1007\/BF02598003"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. <i>Clin Chem<\/i> 1998; 44: 45\u201351.","DOI":"10.1093\/clinchem\/44.1.45"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: A systematic review. <i>Am J Clin Nutr<\/i> 2015; 102: 1585\u20131594.","DOI":"10.3945\/ajcn.114.103366"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Van Aelst LNL, Abraham M, Sadoune M, Lefebvre T, Manivet P, Logeart D, et al. Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: Early in-hospital phase and 30-day follow-up. <i>Eur J Heart Fail<\/i> 2017; 19: 1075\u20131076.","DOI":"10.1002\/ejhf.837"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, et al. Etiology of anemia in patients with advanced heart failure. <i>J Am Coll Cardiol<\/i> 2006; 48: 2485\u20132489.","DOI":"10.1016\/j.jacc.2006.08.034"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. <i>Metallomics<\/i> 2014; 6: 748\u2013773.","DOI":"10.1039\/C3MT00347G"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Moris W, Verhaegh P, Jonkers D, van Deursen C, Koek G. Hyperferritinemia in nonalcoholic fatty liver disease: Iron accumulation or inflammation? <i>Semin Liver Dis<\/i> 2019; 39: 476\u2013482.","DOI":"10.1055\/s-0039-1693114"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Cleland JGF, Kalra PA, Pellicori P, Graham FJ, Foley PWX, Squire IB, et al. Intravenous iron for heart failure, iron deficiency definitions, and clinical response: The IRONMAN trial. <i>Eur Heart J<\/i> 2024; 45: 1410\u20131426.","DOI":"10.1093\/eurheartj\/ehae243"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Ridefelt P, Larsson A, Rehman JU, Axelsson J. Influences of sleep and the circadian rhythm on iron-status indices. <i>Clin Biochem<\/i> 2010; 43: 1323\u20131328.","DOI":"10.1016\/j.clinbiochem.2010.08.023"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Dale JC, Burritt MF, Zinsmeister AR. Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels. <i>Am J Clin Pathol<\/i> 2002; 117: 802\u2013808.","DOI":"10.1309\/2YT4-CMP3-KYW7-9RK1"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Cao GY, Li Y, Jin PF, Hu X. Circadian rhythm in serum iron levels. <i>Biol Trace Elem Res<\/i> 2012; 147: 63\u201366.","DOI":"10.1007\/s12011-011-9304-6"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Crosby WH, O\u2019Neil-Cutting MA. A small-dose iron tolerance test as an indicator of mild iron deficiency. <i>JAMA<\/i> 1984; 251: 1986\u20131987.","DOI":"10.1001\/jama.1984.03340390040026"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Cabrera CC, Ekstr\u00f6m M, Linde C, Persson H, Hage C, Eriksson MJ, et al. Increased iron absorption in patients with chronic heart failure and iron deficiency. <i>J Card Fail<\/i> 2020; 26: 440\u2013443.","DOI":"10.1016\/j.cardfail.2020.03.004"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Camaschella C. Iron deficiency: New insights into diagnosis and treatment. <i>Hematology<\/i> 2015; 2015: 8\u201313.","DOI":"10.1182\/asheducation-2015.1.8"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Wish JB. Assessing iron status: Beyond serum ferritin and transferrin saturation. <i>CJASN<\/i> 2006; 1(Suppl 1): S4\u2013S8.","DOI":"10.2215\/CJN.01490506"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Yamanishi H, Iyama S, Yamaguchi Y, Kanakura Y, Iwatani Y. Total iron-binding capacity calculated from serum transferrin concentration or serum iron concentration and unsaturated iron-binding capacity. <i>Clin Chem<\/i> 2003; 49: 175\u2013178.","DOI":"10.1373\/49.1.175"},{"key":"73","unstructured":"73. World Health Organization. Iron deficiency anaemia: Assessment, prevention and control. WHO, Jan 2001. https:\/\/www.who.int\/publications\/m\/item\/iron-children-6to23--archived-iron-deficiency-anaemia-assessment-prevention-and-control (accessed April 2, 2025)."},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Cohen-Solal A, Leclercq C, Mebazaa A, De Groote P, Damy T, Isnard R, et al. Diagnosis and treatment of iron deficiency in patients with heart failure: Expert position paper from French cardiologists. <i>Arch Cardiovasc Dis<\/i> 2014; 107: 563\u2013571.","DOI":"10.1016\/j.acvd.2014.07.049"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Graham FJ, Pellicori P, Masini G, Cuthbert JJ, Clark AL, Cleland JGF. Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure. <i>ESC Heart Fail<\/i> 2023; 10: 2826\u20132836.","DOI":"10.1002\/ehf2.14438"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Baynes RD. Assessment of iron status. <i>Clin Biochem<\/i> 1996; 29: 209\u2013215.","DOI":"10.1016\/0009-9120(96)00010-K"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. <i>Clin Chim Acta<\/i> 2003; 329: 9\u201322.","DOI":"10.1016\/S0009-8981(03)00005-6"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Fitzsimons EJ, Houston T, Munro R, Sturrock RD, Speekenbrink ABJ, Brock JH. Erythroblast iron metabolism and serum soluble transferrin receptor values in the anemia of rheumatoid arthritis. <i>Arthritis Rheum<\/i> 2002; 47: 166\u2013171.","DOI":"10.1002\/art.10247"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Punnonen K, Irjala K, Rajam\u00e4ki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. <i>Blood<\/i> 1997; 89: 1052\u20131057.","DOI":"10.1182\/blood.V89.3.1052"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J, et al. Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease. <i>BMC Nephrol<\/i> 2017; 18: 345.","DOI":"10.1186\/s12882-017-0688-1"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Jankowska EA, Tkaczyszyn M, Drozd M, Ponikowski P. Monitoring of iron status in patients with heart failure. <i>Eur Heart J<\/i> 2019; 21(Suppl): M32\u2013M35.","DOI":"10.1093\/eurheartj\/suz231"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Michael Felker G, et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency the IRONOUT HF randomized clinical trial. <i>JAMA<\/i> 2017; 317: 1958\u20131966.","DOI":"10.1001\/jama.2017.5427"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Packer M, Anker SD, Butler J, Cleland JGF, Kalra PR, Mentz RJ, et al. Identification of three mechanistic pathways for iron-deficient heart failure. <i>Eur Heart J<\/i> 2024; 45: 2281\u20132293.","DOI":"10.1093\/eurheartj\/ehae284"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Koch TA, Myers J, Goodnough LT. Intravenous iron therapy in patients with iron deficiency anemia: Dosing considerations. <i>Anemia<\/i> 2015; 2015: 763576.","DOI":"10.1155\/2015\/763576"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Stoffel NU, Zeder C, Brittenham GM, Moretti D, Zimmermann MB. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. <i>Haematologica<\/i> 2020; 105: 1232\u20131239.","DOI":"10.3324\/haematol.2019.220830"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. <i>Lancet<\/i> 2016; 387: 907\u2013916.","DOI":"10.1016\/S0140-6736(15)60865-0"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Moore RA, Gaskell H, Rose P, Allan J. Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data. <i>BMC Blood Disord<\/i> 2011; 11: 4.","DOI":"10.1186\/1471-2326-11-4"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Bhandari S, Pereira DIA, Chappell HF, Drakesmith H. Intravenous irons: From basic science to clinical practice. <i>Pharmaceuticals (Basel)<\/i> 2018; 11: 82.","DOI":"10.3390\/ph11030082"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlm\u00e9n J. Update on adverse drug events associated with parenteral iron. <i>Nephrol Dial Transplant<\/i> 2006; 21: 378\u2013382.","DOI":"10.1093\/ndt\/gfi253"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. <i>N Engl J Med<\/i> 2009; 361: 2436\u20132448.","DOI":"10.1056\/NEJMoa0908355"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Ponikowski P, Van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. <i>Eur Heart J<\/i> 2015; 36: 657\u2013668.","DOI":"10.1093\/eurheartj\/ehu385"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Van Veldhuisen DJ, Ponikowski P, Van Der Meer P, Metra M, B\u00f6hm M, Doletsky A, et al. Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. <i>Circulation<\/i> 2017; 136: 1374\u20131383.","DOI":"10.1161\/CIRCULATIONAHA.117.027497"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Salonen JT, Nyyss\u00f6nen K, Korpela H, Tuomilehto J, Sepp\u00e4nen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. <i>Circulation<\/i> 1992; 86: 803\u2013811.","DOI":"10.1161\/01.CIR.86.3.803"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB, et al. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): An investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. <i>Lancet<\/i> 2022; 400: 2199\u20132209.","DOI":"10.1016\/S0140-6736(22)02083-9"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Mentz RJ, Garg J, Rockhold FW, Butler J, De Pasquale CG, Ezekowitz JA, et al. Ferric carboxymaltose in heart failure with iron deficiency. <i>N Engl J Med<\/i> 2023; 389: 975\u2013986.","DOI":"10.1056\/NEJMoa2304968"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Schaefer B, Tobiasch M, Viveiros A, Tilg H, Kennedy NA, Wolf M, et al. Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside: A systematic review and meta-analysis. <i>Br J Clin Pharmacol<\/i> 2021; 87: 2256\u20132273.","DOI":"10.1111\/bcp.14643"},{"key":"97","unstructured":"97. European Medicines Agency. Iron (parenteral preparations, except for iron dextran). Annex I: Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s). 2020. https:\/\/www.ema.europa.eu\/en\/documents\/psusa\/iron-parenteral-preparations-except-iron-dextran-cmdh-scientific-conclusions-and-grounds-variation-amendments-product-information-and-timetable-implementation-psusa00010236202001_en.pdf (accessed November 29, 2021)."},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. Ambrosy AP, von Haehling S, Kalra PR, Court E, Bhandari S, McDonagh T, et al. Safety and efficacy of intravenous ferric derisomaltose compared to iron sucrose for iron deficiency anemia in patients with chronic kidney disease with and without heart failure. <i>Am J Cardiol<\/i> 2021; 152: 138\u2013145.","DOI":"10.1016\/j.amjcard.2021.04.042"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Auerbach M, Macdougall I. The available intravenous iron formulations: History, efficacy, and toxicology. <i>Hemodial Int<\/i> 2017; 21: S83\u2013S92.","DOI":"10.1111\/hdi.12560"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: Systematic review and meta-analysis of randomised clinical trials. <i>BMJ<\/i> 2013; 347: f4822.","DOI":"10.1136\/bmj.f4822"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. Vera-Aviles M, Kabir SN, Shah A, Polzella P, Lim DY, Buckley P, et al. Intravenous iron therapy results in rapid and sustained rise in myocardial iron content through a novel pathway. <i>Eur Heart J<\/i> 2024; 45: 4497\u20134508.","DOI":"10.1093\/eurheartj\/ehae359"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Lakhal-Littleton S, Cleland JGF. Iron deficiency and supplementation in heart failure. <i>Nat Rev Cardiol<\/i> 2024; 21: 463\u2013486.","DOI":"10.1038\/s41569-024-00988-1"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. Foley PW, Kalra PR, Cleland JGF, Petrie MC, Kalra PA, Squire I, et al. Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trial. <i>Eur J Heart Fail<\/i> 2025; 27: 166\u2013173.","DOI":"10.1002\/ejhf.3504"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. Cleland JGF, Pellicori P, Graham FJ, Lane R, Petrie MC, Ahmed F, et al. Adjudication of hospitalizations and deaths in the IRONMAN trial of intravenous iron for heart failure. <i>J Am Coll Cardiol<\/i> 2024; 84: 1704\u20131717.","DOI":"10.1016\/j.jacc.2024.08.052"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105. Das De S, Krishna S, Jethwa A. Iron status and its association with coronary heart disease: Systematic review and meta-analysis of prospective studies. <i>Atherosclerosis<\/i> 2015; 238: 296\u2013303.","DOI":"10.1016\/j.atherosclerosis.2014.12.018"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106. Gill D, Del Greco FM, Walker AP, Srai SKS, Laffan MA, Minelli C. The effect of iron status on risk of coronary artery disease: A Mendelian randomization study [Brief Report]. <i>Arterioscler Thromb Vasc Biol<\/i> 2017; 37: 1788\u20131792.","DOI":"10.1161\/ATVBAHA.117.309757"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107. Barad A, Clark AG, Pressman EK, O\u2019Brien KO. Associations between genetically predicted iron status and cardiovascular disease risk: A Mendelian randomization study. <i>J Am Heart Assoc<\/i> 2024; 13: 34991.","DOI":"10.1161\/JAHA.124.034991"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108. Grammer TB, Kleber ME, Silbernagel G, Pilz S, Scharnagl H, Tomaschitz A, et al. Hemoglobin, iron metabolism and angiographic coronary artery disease (The Ludwigshafen risk and cardiovascular health study). <i>Atherosclerosis<\/i> 2014; 236: 292\u2013300.","DOI":"10.1016\/j.atherosclerosis.2014.07.002"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109. Ponikowska B, Suchocki T, Paleczny B, Olesinska M, Powierza S, Borodulin-Nadzieja L, et al. Iron status and survival in diabetic patients with coronary artery disease. <i>Diabetes Care<\/i> 2013; 36: 4147\u20134156.","DOI":"10.2337\/dc13-0528"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110. Corradi F, Masini G, Bucciarelli T, De Caterina R. Iron deficiency in myocardial ischaemia: Molecular mechanisms and therapeutic perspectives. <i>Cardiovasc Res<\/i> 2023; 119: 2405\u20132420.","DOI":"10.1093\/cvr\/cvad146"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111. Petrie MC, Jhund PS, Connolly E, Mark PB, MacDonald MR, Robertson M, et al. High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis. <i>Cardiovasc Res<\/i> 2023; 119: 213\u2013220.","DOI":"10.1093\/cvr\/cvab317"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112. Jen\u010da D, Melenovsk\u00fd V, Mr\u00e1zkov\u00e1 J, Marek\u0161ramko MM, Kotr\u010d M, Michael\u017eel\u00edzko MM, et al. Iron deficiency and all-cause mortality after myocardial infarction. <i>Eur J Intern Med<\/i> 2024; 126: 102\u2013108.","DOI":"10.1016\/j.ejim.2024.04.020"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113. Stirrat CG, Alam SR, MacGillivray TJ, Gray CD, Dweck MR, Raftis J, et al. Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction. <i>Heart<\/i> 2017; 103: 1528\u20131535.","DOI":"10.1136\/heartjnl-2016-311018"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114. Bulluck H, Rosmini S, Abdel-Gadir A, White SK, Bhuva AN, Treibel TA, et al. Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused ST-segment-elevation myocardial infarction and adverse left ventricular remodeling. <i>Circ Cardiovasc Imaging<\/i> 2016; 9: e004940.","DOI":"10.1161\/CIRCIMAGING.116.004940"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115. Roghi A, Poggiali E, Duca L, Mafrici A, Pedrotti P, Paccagnini S, et al. Role of Non-Transferrin-Bound Iron in the pathogenesis of cardiotoxicity in patients with ST-elevation myocardial infarction assessed by Cardiac Magnetic Resonance Imaging. <i>Int J Cardiol<\/i> 2015; 199: 326\u2013332.","DOI":"10.1016\/j.ijcard.2015.07.056"},{"key":"116","doi-asserted-by":"crossref","unstructured":"116. Inserte J, Barrab\u00e9s JA, Aluja D, Otaegui I, Ba\u00f1eras J, Castellote L, et al. Implications of iron deficiency in STEMI patients and in a murine model of myocardial infarction. <i>JACC Basic Transl Sci<\/i> 2021; 6: 567\u2013580.","DOI":"10.1016\/j.jacbts.2021.05.004"},{"key":"117","doi-asserted-by":"crossref","unstructured":"117. Masini G, Barsacchi M, Chiusolo S, Alberti M, Gargani L, Corradi F, et al. Iron deficiency in acute coronary syndromes: Clinical correlates and outcomes. <i>Am J Med<\/i> 2025; 138: 1099\u20131105.e6.","DOI":"10.1016\/j.amjmed.2025.03.003"},{"key":"118","doi-asserted-by":"crossref","unstructured":"118. Cosentino N, Campodonico J, Pontone G, Guglielmo M, Trinei M, Sandri MT, et al. Iron deficiency in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. <i>Int J Cardiol<\/i> 2020; 300: 14\u201319.","DOI":"10.1016\/j.ijcard.2019.07.083"},{"key":"119","doi-asserted-by":"crossref","unstructured":"119. Florian A, Ludwig A, R\u00f6sch S, Yildiz H, Klumpp S, Sechtem U, et al. Positive effect of intravenous iron-oxide administration on left ventricular remodelling in patients with acute ST-elevation myocardial infarction: A cardiovascular magnetic resonance (CMR) study. <i>Int J Cardiol<\/i> 2014; 173: 184\u2013189.","DOI":"10.1016\/j.ijcard.2014.02.016"},{"key":"120","doi-asserted-by":"crossref","unstructured":"120. Ebner N, Jankowska EA, Ponikowski P, Lainscak M, Elsner S, Sliziuk V, et al. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure: Results from the Studies Investigating Co-morbidities Aggravating Heart Failure. <i>Int J Cardiol<\/i> 2016; 205: 6\u201312.","DOI":"10.1016\/j.ijcard.2015.11.178"},{"key":"121","doi-asserted-by":"crossref","unstructured":"121. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. <i>J Am Coll Cardiol<\/i> 2002; 39: 1780\u20131786.","DOI":"10.1016\/S0735-1097(02)01854-5"},{"key":"122","doi-asserted-by":"crossref","unstructured":"122. Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, et al. Treatment of anemia with darbepoetin alfa in systolic heart failure. <i>N Engl J Med<\/i> 2013; 368: 1210\u20131219.","DOI":"10.1056\/NEJMoa1214865"},{"key":"123","doi-asserted-by":"crossref","unstructured":"123. Hirsch VG, Tongers J, Bode J, Berliner D, Widder JD, Escher F, et al. Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction. <i>Eur J Heart Fail<\/i> 2020; 22: 2038\u20132046.","DOI":"10.1002\/ejhf.1781"},{"key":"124","doi-asserted-by":"crossref","unstructured":"124. Hoes MF, Grote Beverborg N, Kijlstra JD, Kuipers J, Swinkels DW, Giepmans BNG, et al. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. <i>Eur J Heart Fail<\/i> 2018; 20: 910\u2013919.","DOI":"10.1002\/ejhf.1154"},{"key":"125","doi-asserted-by":"crossref","unstructured":"125. McMurray J, Ponikowski P. Heart failure: Not enough pump iron? <i>J Am Coll Cardiol<\/i> 2011; 58: 481\u2013482.","DOI":"10.1016\/j.jacc.2011.02.066"},{"key":"126","doi-asserted-by":"crossref","unstructured":"126. Charles-Edwards G, Amaral N, Sleigh A, Ayis S, Catibog N, McDonagh T, et al. Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency: FERRIC-HF II randomized mechanistic trial. <i>Circulation<\/i> 2019; 139: 2386\u20132398.","DOI":"10.1161\/CIRCULATIONAHA.118.038516"},{"key":"127","unstructured":"127. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. <i>Eur Heart J<\/i> 2021; 42: 3599\u20133726 (Corrigendum: <i>Eur Heart J<\/i> 2021; <b>42<\/b>: 4901)."},{"key":"128","unstructured":"128. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2022; 79: e263\u2013e421."},{"key":"129","doi-asserted-by":"crossref","unstructured":"129. Cuthbert JJ, Ransome N, Clark AL. Re-defining iron deficiency in patients with heart failure. <i>Expert Rev Cardiovasc Ther<\/i> 2022; 20: 667\u2013681.","DOI":"10.1080\/14779072.2022.2100349"},{"key":"130","doi-asserted-by":"crossref","unstructured":"130. Sierpinski R, Josiak K, Suchocki T, Wojtas-Polc K, Mazur G, Butrym A, et al. High soluble transferrin receptor in patients with heart failure: A measure of iron deficiency and a strong predictor of mortality. <i>Eur J Heart Fail<\/i> 2021; 23: 919\u2013932.","DOI":"10.1002\/ejhf.2036"},{"key":"131","doi-asserted-by":"crossref","unstructured":"131. Moliner P, Jankowska EA, van Veldhuisen DJ, Farre N, Rozentryt P, Enjuanes C, et al. Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure. <i>Int J Cardiol<\/i> 2017; 243: 360\u2013366.","DOI":"10.1016\/j.ijcard.2017.04.110"},{"key":"132","doi-asserted-by":"crossref","unstructured":"132. Cleland JGF. Defining iron deficiency in patients with heart failure. <i>Nat Rev Cardiol<\/i> 2024; 21: 1\u20132.","DOI":"10.1038\/s41569-023-00951-6"},{"key":"133","doi-asserted-by":"crossref","unstructured":"133. Martens P, Dupont M, Dauw J, Nijst P, Herbots L, Dendale P, et al. The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy: The IRON-CRT trial. <i>Eur Heart J<\/i> 2021; 42: 4905\u20134914.","DOI":"10.1093\/eurheartj\/ehab411"},{"key":"134","doi-asserted-by":"crossref","unstructured":"134. Graham FJ, Guha K, Cleland JG, Kalra PR. Treating iron deficiency in patients with heart failure: What, why, when, how, where and who. <i>Heart<\/i> 2024; 110: 1201\u20131207.","DOI":"10.1136\/heartjnl-2022-322030"},{"key":"135","doi-asserted-by":"crossref","unstructured":"135. Barakat MF, Amin-Youseff G, Okonko DO. Oral sucrosomial iron in heart failure with a reduced ejection fraction. <i>Eur J Heart Fail<\/i> 2021; 23: 598\u2013600.","DOI":"10.1002\/ejhf.2176"},{"key":"136","doi-asserted-by":"crossref","unstructured":"136. Karavidas A, Troganis E, Lazaros G, Balta D, Karavidas I, Polyzogopoulou E, et al. Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: A non-randomized, open-label, proof-of-concept study. <i>Eur J Heart Fail<\/i> 2021; 23: 593\u2013597.","DOI":"10.1002\/ejhf.2092"},{"key":"137","doi-asserted-by":"crossref","unstructured":"137. Anker SD, Friede T, Butler J, Talha KM, Placzek M, Diek M, et al. Intravenous ferric carboxymaltose in heart failure with iron deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial. <i>JAMA<\/i> 2025; 333: 1965\u20131976.","DOI":"10.1001\/jama.2025.3833"},{"key":"138","doi-asserted-by":"publisher","unstructured":"138. Anker SD, Karakas M, Mentz RJ, Ponikowski P, Butler J, Khan MS, et al. Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency. <i>Nat Med<\/i> 2025, doi:10.1038\/s41591-025-03671-1.","DOI":"10.1038\/s41591-025-03671-1"},{"key":"139","doi-asserted-by":"crossref","unstructured":"139. Fishbane S, Pollack S, Feldman HI, Joffe MM. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988\u20132004. <i>Clin J Am Soc Nephrol<\/i> 2009; 4: 57\u201361.","DOI":"10.2215\/CJN.01670408"},{"key":"140","doi-asserted-by":"crossref","unstructured":"140. Keskin M, Ural D, Altay S, Argan O, B\u00f6rkl\u00fc EB, Kozan \u00d6. Iron deficiency and hematinic deficiencies in atrial fibrillation: A new insight into comorbidities. <i>Turk Kardiyoloji Dernegi Arsivi<\/i> 2018; 46: 103\u2013110.","DOI":"10.5543\/tkda.2018.51001"},{"key":"141","doi-asserted-by":"crossref","unstructured":"141. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, et al. 2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. <i>Circulation<\/i> 2017; 136: e137\u2013e161.","DOI":"10.1161\/CIR.0000000000000509"},{"key":"142","doi-asserted-by":"crossref","unstructured":"142. von Haehling S, Doehner W, Evertz R, Garfias-Veitl T, Derad C, Diek M, et al. Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: The FAIR-HFpEF trial. <i>Eur Heart J<\/i> 2024; 45: 3789\u20133800.","DOI":"10.1093\/eurheartj\/ehae479"},{"key":"143","doi-asserted-by":"crossref","unstructured":"143. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, et al. Hemodilution is common in patients with advanced heart failure. <i>Circulation<\/i> 2003; 107: 226\u2013229.","DOI":"10.1161\/01.CIR.0000052623.16194.80"},{"key":"144","doi-asserted-by":"crossref","unstructured":"144. Yeo TJ, Yeo PSD, Hadi FA, Cushway T, Lee KY, Yin FF, et al. Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF). <i>ESC Heart Fail<\/i> 2018; 5: 344\u2013353.","DOI":"10.1002\/ehf2.12250"},{"key":"145","doi-asserted-by":"crossref","unstructured":"145. Lee M, Petrie M, Lang N, Cleland J, Hannah A, Japp A, et al. [137] Efficacy of intravenous ferric derisomaltose in hospitalised and outpatient settings: Insights from ironman trial. <i>Heart<\/i> 2024; 110(Suppl 3): A143\u2013A145.","DOI":"10.1136\/heartjnl-2024-BCS.135"},{"key":"146","doi-asserted-by":"crossref","unstructured":"146. Logeart D, Isnard R, Resche-Rigon M, Seronde MF, de Groote P, Jondeau G, et al. Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: The OFICA study. <i>Eur J Heart Fail<\/i> 2013; 15: 465\u2013476.","DOI":"10.1093\/eurjhf\/hfs189"},{"key":"147","doi-asserted-by":"crossref","unstructured":"147. Pagano D, Milojevic M, Meesters MI, Benedetto U, Bolliger D, Heymann C von, et al. 2017 EACTS\/EACTA Guidelines on patient blood management for adult cardiac surgery: The task force on patient blood management for adult cardiac surgery of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Cardiothoracic Anaesthesiology (EACTA). <i>Eur J Cardiothorac Surg<\/i> 2018; 53: 79\u2013111.","DOI":"10.1093\/ejcts\/ezx325"},{"key":"148","doi-asserted-by":"crossref","unstructured":"148. Mehta RH, Castelvecchio S, Ballotta A, Frigiola A, Bossone E, Ranucci M. Association of gender and lowest hematocrit on cardiopulmonary bypass with acute kidney injury and operative mortality in patients undergoing cardiac Surgery. <i>Ann Thorac Surg<\/i> 2013; 96: 133\u2013140.","DOI":"10.1016\/j.athoracsur.2013.03.033"},{"key":"149","doi-asserted-by":"crossref","unstructured":"149. Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. <i>Circulation<\/i> 2007; 116: 2544\u20132552.","DOI":"10.1161\/CIRCULATIONAHA.107.698977"},{"key":"150","doi-asserted-by":"crossref","unstructured":"150. Hung M, Ortmann E, Besser M, Martin-Cabrera P, Richards T, Ghosh M, et al. A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients. <i>Heart<\/i> 2015; 101: 107\u2013112.","DOI":"10.1136\/heartjnl-2014-305856"},{"key":"151","doi-asserted-by":"crossref","unstructured":"151. Lawrence VA, Silverstein JH, Cornell JE, Pederson T, Noveck H, Carson JL. Higher Hb level is associated with better early functional recovery after hip fracture repair. <i>Transfusion (Paris)<\/i> 2003; 43: 1717\u20131722.","DOI":"10.1046\/j.0041-1132.2003.00581.x"},{"key":"152","doi-asserted-by":"crossref","unstructured":"152. Corwin HL, Shander A, Speiss B, Mu\u00f1oz M, Faraoni D, Calcaterra D, et al. Management of perioperative iron deficiency in cardiac surgery: A modified RAND Delphi study. <i>Ann Thorac Surg<\/i> 2022; 113: 316\u2013323.","DOI":"10.1016\/j.athoracsur.2020.11.031"},{"key":"153","doi-asserted-by":"crossref","unstructured":"153. Mu\u00f1oz M, Acheson AG, Auerbach M, Besser M, Habler O, Kehlet H, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. <i>Anaesthesia<\/i> 2017; 72: 233\u2013247.","DOI":"10.1111\/anae.13773"},{"key":"154","doi-asserted-by":"crossref","unstructured":"154. R\u00f6ssler J, Schoenrath F, Seifert B, Kaserer A, Spahn GH, Falk V, et al. Iron deficiency is associated with higher mortality in patients undergoing cardiac surgery: A prospective study. <i>Br J Anaesth<\/i> 2020; 124: 25\u201334.","DOI":"10.1016\/j.bja.2019.09.016"},{"key":"155","doi-asserted-by":"crossref","unstructured":"155. Spahn DR, Schoenrath F, Spahn GH, Seifert B, Stein P, Theusinger OM, et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: A prospective randomised trial. <i>Lancet<\/i> 2019; 393: 2201\u20132212.","DOI":"10.1016\/S0140-6736(18)32555-8"},{"key":"156","doi-asserted-by":"crossref","unstructured":"156. Kvaslerud AB, Hussain AI, Auensen A, Ueland T, Michelsen AE, Pettersen KI, et al. Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis. <i>Open Heart<\/i> 2018; 5: e000901.","DOI":"10.1136\/openhrt-2018-000901"},{"key":"157","doi-asserted-by":"crossref","unstructured":"157. Rheude T, Pellegrini C, Lessmann L, Wiebe J, Mayr NP, Michel J, et al. Prevalence and clinical impact of iron deficiency in patients with severe aortic stenosis referred for transcatheter aortic valve implantation. <i>Am J Cardiol<\/i> 2019; 124: 1442\u20131448.","DOI":"10.1016\/j.amjcard.2019.07.051"},{"key":"158","doi-asserted-by":"crossref","unstructured":"158. Martens P, Yu S, Larive B, Borlaug BA, Erzurum SC, Farha S, et al. Iron deficiency in pulmonary vascular disease: Pathophysiological and clinical implications. <i>Eur Heart J<\/i> 2023; 44: 1979\u20131991.","DOI":"10.1093\/eurheartj\/ehad149"},{"key":"159","doi-asserted-by":"crossref","unstructured":"159. Van Empel VPM, Lee J, Williams TJ, Kaye DM. Iron deficiency in patients with idiopathic pulmonary arterial hypertension. <i>Heart Lung Circ<\/i> 2014; 23: 287\u2013292.","DOI":"10.1016\/j.hlc.2013.08.007"},{"key":"160","doi-asserted-by":"crossref","unstructured":"160. Rhodes CJ, Howard LS, Busbridge M, Ashby D, Kondili E, Gibbs JSR, et al. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension. <i>J Am Coll Cardiol<\/i> 2011; 58: 300\u2013309.","DOI":"10.1016\/j.jacc.2011.02.057"},{"key":"161","doi-asserted-by":"crossref","unstructured":"161. Viethen T, Gerhardt F, Dumitrescu D, Knoop-Busch S, Ten Freyhaus H, Rudolph TK, et al. Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: A pilot study. <i>Int J Cardiol<\/i> 2014; 175: 233\u2013239.","DOI":"10.1016\/j.ijcard.2014.04.233"},{"key":"162","doi-asserted-by":"crossref","unstructured":"162. Lakhal-Littleton S, Crosby A, Frise MC, Mohammad G, Carr CA, Loick PAM, et al. Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice. <i>Proc Natl Acad Sci USA<\/i> 2019; 116: 13122\u201313130.","DOI":"10.1073\/pnas.1822010116"},{"key":"163","doi-asserted-by":"crossref","unstructured":"163. Camilli M, Ballacci F, Rossi VA, Cannat\u00e0 A, Monzo L, Mewton N, et al. Iron deficiency and supplementation in patients with heart failure: Results from the IRON-HF international survey. <i>Eur J Heart Fail<\/i> 2025; 27: 140\u2013147.","DOI":"10.1002\/ejhf.3356"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/5\/90_CJ-25-0220\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:19:39Z","timestamp":1777087179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/5\/90_CJ-25-0220\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":163,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-0220","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"CJ-25-0220"}}